Inducing Apoptosis through Upregulation of p53: Structure-Activity Exploration of Anthraquinone Analogs

Abiodun Anifowose1, Ayodeji A Agbowuro1, Ravi Tripathi1

  • 1Department of Chemistry and Center for Diagnostics and Therapeutics, Georgia State University, Petit Science Center, 100 Piedmont Ave, Atlanta, GA 30303, United States.

Insights

New anthraquinone derivatives show cytotoxicity against acute lymphatic leukemia (ALL) cells by elevating p53. However, the anthraquinone core is crucial for regulating MDM2, guiding future drug development.

Area of Science:

  • Medicinal Chemistry
  • Oncology
  • Molecular Biology

Background:

  • Previous research identified p53-elevating anthraquinone compounds with cytotoxicity against acute lymphatic leukemia (ALL).
  • Further investigation is needed to understand the structure-activity relationship (SAR) of these compounds for optimized therapeutic potential.

Purpose of the Study:

  • To examine the impact of key structural features on the anticancer activity of anthraquinone derivatives in ALL cells.
  • To elucidate the mechanism of action, specifically regarding p53 and MDM2 regulation.

Main Methods:

  • Synthesis and evaluation of novel anthraquinone analogs.
  • Assessment of cytotoxicity against ALL cell lines.
  • Analysis of p53 and MDM2 protein levels via Western blotting or similar techniques.

Main Results:

  • Active analogs demonstrated significant cytotoxicity and p53 upregulation in ALL cells.
  • Unlike the lead compound AQ-101, these analogs did not significantly downregulate MDM2.
  • The anthraquinone core scaffold was identified as essential for MDM2 regulation.

Conclusions:

  • The anthraquinone core is critical for the MDM2-regulating activity of these compounds.
  • The study provides a refined SAR framework for anthraquinone derivatives targeting ALL.
  • New avenues for chemical space exploration and optimization of anticancer agents are identified.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
7.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
7.7K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.0K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.8K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
2.9K